Older AdultsInterpersonal Functioning & Social Connectedness

Classic Psychedelic Use and Current Meditation Practice

This survey study (n=2822) finds a correlation between lifetime classical psychedelic use (n=613) and a higher frequency of current mindfulness meditation (but not compassion meditation) practice. When analysing psychological insight (an aspect of the acute psychedelic experience), a correlation with both types of meditation was found.

Authors

  • Otto Simonsson
  • Peter Hendricks
  • Wojciech Osika

Published

Mindfulness
individual Study

Abstract

Objectives

Previous research has investigated potential synergies between classic psychedelics and meditation practice, but relatively little remains known about the relationship between classic psychedelic experiences and engagement with meditation practice. The purpose of this study was to investigate associations between classic psychedelic experiences and engagement with two popular types of meditation: mindfulness meditation and loving-kindness or compassion meditation.

Method

This retrospective, population-based observational study included 2822 respondents aged 18 years or older in the United States. Using covariate-adjusted regression models, this study examined associations of classic psychedelic experiences with current practice of mindfulness meditation and loving-kindness or compassion meditation.

Results

In covariate-adjusted regression models, lifetime classic psychedelic use was associated with a higher frequency of current mindfulness meditation practice but not current loving-kindness or compassion meditation practice. Both psychological insight and “ego dissolution” were associated with a higher frequency of current mindfulness meditation practice and current loving-kindness or compassion meditation practice. Notably, when psychological insight and “ego dissolution” were entered into the regression model simultaneously, only greater psychological insight was associated with having a higher frequency of current mindfulness meditation practice and current loving-kindness or compassion meditation practice.

Conclusions

Although the findings in this study cannot demonstrate causality, they suggest that classic psychedelic experiences may exert a positive effect on the cultivation and maintenance of health-related behaviors such as regular meditation practice, with psychological insight appearing to be a stronger predictor than “ego dissolution.”

Unlocked with Blossom Pro

Research Summary of 'Classic Psychedelic Use and Current Meditation Practice'

Editorial

βBlossom's Take

This survey is useful because it asks a concrete question that often stays vague, whether lifetime classic psychedelic use relates to current meditation habits. The association with mindfulness, but not compassion practice, and the stronger links with insight and ego dissolution, make the meditation synergy literature more specific, even if the cross-sectional design cannot separate cause from selection.

Introduction

Previous research has suggested potential synergies between classic psychedelics and meditation practice, and has identified acute phenomenological features of psychedelic experiences—commonly labelled "ego dissolution" (reduced self-focus) and psychological insight (realizations about relationships, personality, or behaviour)—as relevant to mental health outcomes. Prior cross-sectional work found that greater ego dissolution during respondents' most intense classic psychedelic experience was associated with having tried meditation, lower perceived barriers to meditation among meditators, and a more frequent meditation practice. That earlier work did not, however, examine psychological insight as a predictor of meditation practice despite prior links between insight and other health behaviours such as diet and exercise. Simonsson and colleagues set out to examine associations between classic psychedelic experiences and current engagement with two common meditation practices: mindfulness meditation and loving-kindness/compassion meditation. Using a large, nationally stratified US sample, the study tested the hypothesis that greater psychological insight during an individual's most insightful classic psychedelic experience would be associated with more frequent current mindfulness and loving-kindness/compassion practice. An exploratory analysis compared the relative strength of psychological insight and ego dissolution as predictors of meditation practice.

Methods

This was a retrospective, population-based observational study conducted in October 2021. The investigators recruited 2,822 US adults aged 18 or older via Prolific Academic, using that platform's representativeness function to stratify the sample by sex, age, and ethnicity to reflect the US adult population. Sample size planning with G*Power targeted approximately 2,800 participants to obtain sufficient numbers of lifetime classic psychedelic users; the authors expected about 14% prevalence but ultimately had 613 respondents who reported lifetime classic psychedelic use. Study procedures were approved by the University of Wisconsin–Madison Institutional Review Board and participants received US$2.20 for completing the survey. Respondents reported demographic characteristics (age, gender, educational attainment), lifetime use of cocaine, and alcohol-related risk behaviour measured with the 3-item AUDIT-Concise. Classic psychedelic use was assessed by asking whether participants had ever used any of the following: DMT, ayahuasca, LSD, mescaline, peyote, San Pedro, or psilocybin. Participants endorsing any of these agents were coded as lifetime classic psychedelic users (yes/no). Those reporting lifetime use (n = 613) completed two psychometric measures adapted to refer to their most relevant psychedelic episode: the Psychological Insight Questionnaire (23 items, 6-point scale, averaged to a total score; internal consistency Cronbach's α = 0.98) and the Ego Dissolution Inventory (8 items, 0–100 scale, averaged; Cronbach's α = 0.91). The instruction for the insight measure referred to the most insightful experience, whereas the ego-dissolution measure referred to the most intense experience. Meditation variables were self-reported. All respondents indicated whether they had ever tried meditation; those who had were asked separately about mindfulness meditation (examples provided, e.g., Vipassana, MBSR) and loving-kindness/compassion meditation (examples provided, e.g., Metta, CCT). For each type, participants estimated average days per week over the past 30 days they practised (0–7), with no experience coded as 0. To test associations, the authors fitted linear regression models with lifetime classic psychedelic use (binary), psychological insight (z-scored), and ego dissolution (z-scored) as independent variables and current meditation frequency as dependent variables. All models adjusted for age, gender, educational attainment, lifetime cocaine use, and problematic alcohol use.

Results

The sample comprised 2,822 respondents, of whom 613 reported lifetime classic psychedelic use. Both psychometric scales administered to lifetime users showed excellent internal consistency (Psychological Insight Questionnaire α = 0.98; Ego Dissolution Inventory α = 0.91). In covariate-adjusted linear regression models, lifetime classic psychedelic use was associated with a higher frequency of current mindfulness meditation practice but was not associated with current loving-kindness or compassion meditation practice. Greater psychological insight during respondents' most insightful classic psychedelic experience was associated with a higher frequency of both current mindfulness meditation practice and current loving-kindness/compassion practice. Greater ego dissolution during respondents' most intense classic psychedelic experience was also associated with a higher frequency of both meditation types when modelled separately. Notably, when psychological insight and ego dissolution were entered simultaneously into the same regression model, only greater psychological insight remained significantly associated with higher frequency of both mindfulness and loving-kindness/compassion practice. The authors report these joint-model effects as moderate in size. Analyses were adjusted for the pre-specified covariates; exact regression coefficients, confidence intervals and p-values are reported in the study tables (not reproduced in the extracted text).

Discussion

The investigators interpret the findings as consistent with the idea that classic psychedelic experiences may positively influence the cultivation and maintenance of regular meditation practice, with psychological insight emerging as a stronger predictor of current practice frequency than ego dissolution. They suggest that if a causal relationship exists, classic psychedelics could increase motivation for meditation and potentially reduce attrition in meditation-based interventions. Conversely, meditation practice might serve as a useful integration strategy following psychedelic experiences; the authors note phenomenological and neurophysiological similarities between mindfulness and loving-kindness/compassion techniques and classic psychedelics (for example, increased present-moment awareness and sense of connection). The paper acknowledges several limitations that constrain interpretation. Because the design is cross-sectional and retrospective, causality cannot be established; it remains possible that enduring meditators experience greater psychological insight during psychedelic episodes, or that unmeasured traits (for example, absorption) explain the associations. The temporal ordering of psychedelic use and meditation practice cannot be inferred from the lifetime-use predictor. Representativeness was limited to stratification on sex, age and ethnicity, so the sample may not reflect the population on other relevant variables (for example, socioeconomic status). Recall bias and the sole use of self-report measures are noted concerns. The authors also point out that they did not assess set and setting variables that influence psychedelic effects, and that the different framing of the two psychometric measures ("most insightful" versus "most intense") may have affected responses. Finally, they recommend future research employ more comprehensive assessments of meditation practice and longitudinal designs to investigate potential causal relationships and mechanisms.

Study Details

References (19)

Papers cited by this study that are also in Blossom

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

623 cited
How do psychedelics work?

Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)

136 cited
Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)

1334 cited
Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

634 cited
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD

Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)

165 cited
Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)

Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)

475 cited
Show all 19 references
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice

Payne, J. E., Chambers, R., Liknaitzky, P. · ACS Pharmacology and Translational Science (2021)

79 cited
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience

Peill, J. M., Trinci, K. E., Kettner, H. et al. · Journal of Psychopharmacology (2022)

134 cited
Psilocybin-Assisted Compassion Focused Therapy for Depression

Pots, W., Chakhssi, F. · Frontiers in Psychology (2022)

29 cited
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

Neil, J. C., Nutt, D. J. · Journal of Psychopharmacology (2022)

315 cited
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States

Simonsson, O., Goldberg, S. B. · Journal of Psychoactive Drugs (2022)

37 cited
Associations between lifetime classic psychedelic use and markers of physical health

Simonsson, O., Sexton, J. D., Hendricks, P. S. · Journal of Psychopharmacology (2021)

75 cited
Classic psychedelics, health behavior, and physical health

Simonsson, O., Hendricks, P. S., Chambers, R. et al. · Therapeutic Advances in Psychopharmacology (2022)

26 cited
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)

171 cited
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution

Uthaug, M. V., Van Oorsouw, &. K., Kuypers, &. K. P. C. et al. · Psychopharmacology (2018)

213 cited

Cited By (7)

Papers in Blossom that reference this study

Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat

Schlomberg, J. T. T., Meling, D., Grylka, R. et al. · Scientific Reports (2026)

Insights on Psychedelics: A Systematic Review of Therapeutic Effects

Kugel, J., Laukkonen, R., Yaden, D. B. et al. · Neuroscience and Biobehavioral Reviews (2025)

11 cited
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat

Meling, D., Egger, K., Aicher, H. D. et al. · Journal of Psychopharmacology (2024)

14 cited
15 cited
Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study

Borkel, L. F., Rojas-Hernández, J., Henríquez-Hernández, L. A. et al. · Expert Review of Clinical Pharmacology (2023)

37 cited
Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom

Simonsson, O., Osika, W., Stenfors, C. U. D. et al. · Psychological Medicine (2023)

14 cited
Classic Psychedelic Use and Current Meditation... — Research Summary & Context | Blossom